On May 27, British Columbia became the first province to expand the use of biosimilars/biogenerics. Find out what this means for the more than 800,000 people in BC living with arthritis.

To read our frequently asked questions on biosimilars/biogenerics, please click here.

Share This

Share on Social Media

Share a message of hope...

Share This

Share this post with your friends!